An Open-Label, Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects Under Seizure and Normal Conditions
Phase of Trial: Phase I
Latest Information Update: 10 Nov 2016
At a glance
- Drugs Diazepam (Primary)
- Indications Epilepsy; Generalised epilepsy; Partial epilepsies
- Focus Pharmacokinetics
- Sponsors Neurelis
- 03 Nov 2016 Status changed from not yet recruiting to recruiting.
- 29 Jul 2016 Planned initiation date changed from 1 Apr 2016 to 1 Jul 2016.
- 04 Apr 2016 New trial record